New Insights Into Second-Line (2L) Choices After Cdk4/6 Inhibitors (Cdk4/6I) In Hormone Receptor-Positive (Hr+)/ Human Epidermal Growth Factor 2-Negative (Her2-) Metastatic Breast Cancer (Mbc) Patients (Pts): Preliminary Results Of The Hermione-13 Study
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: New Insights Into Second-Line (2L) Choices After Cdk4/6 Inhibitors (Cdk4/6I) In Hormone Receptor-Positive (Hr+)/ Human Epidermal Growth Factor 2-Negative (Her2-) Metastatic Breast Cancer (Mbc) Patients (Pts): Preliminary Results Of The Hermione-13 Study ### Output: 